Phathom Pharmaceuticals, Inc. — All Filings
467 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0001209191-22-029453 | May 16, 2022 | — |
| 10-Q | 10-Q | 0000950170-22-008741 | May 10, 2022 | Mar 31, 2022 |
| 8-K | 8-K | 0001193125-22-145742 | May 10, 2022 | — |
| 8-K | 8-K | 0001193125-22-138893 | May 4, 2022 | May 3, 2022 |
| 8-K | 8-K | 0001193125-22-139537 | May 4, 2022 | May 3, 2022 |
| 8-K | 8-K | 0001193125-22-118940 | Apr 26, 2022 | Apr 25, 2022 |
| 3 | FORM 3 SUBMISSION | 0001209191-22-025657 | Apr 26, 2022 | Apr 25, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-025660 | Apr 26, 2022 | Apr 25, 2022 |
| DEFA14A | DEFA14A | 0001193125-22-118946 | Apr 26, 2022 | — |
| DEFA14A | DEFA14A | 0000950170-22-005598 | Apr 12, 2022 | — |
| DEF 14A | DEF 14A | 0000950170-22-005595 | Apr 12, 2022 | May 25, 2022 |
| 3 | FORM 3 SUBMISSION | 0001209191-22-023559 | Apr 6, 2022 | Apr 5, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-023561 | Apr 6, 2022 | Apr 5, 2022 |
| 8-K | 8-K | 0001193125-22-086616 | Mar 28, 2022 | Mar 22, 2022 |
| 8-K | 8-K | 0001193125-22-074137 | Mar 14, 2022 | — |
| 4/A | FORM 4/A SUBMISSION | 0001209191-22-018225 | Mar 11, 2022 | Jan 19, 2022 |
| S-8 | S-8 | 0001193125-22-071935 | Mar 10, 2022 | — |
| 10-K | 10-K | 0000950170-22-002536 | Mar 1, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0001193125-22-061320 | Mar 1, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-011484 | Feb 18, 2022 | Oct 29, 2019 |
| SC 13G/A | PHATHOM PHARMACEUTICALS, INC. | 0001104659-22-022756 | Feb 14, 2022 | — |
| SC 13G | — | 0000919574-22-000995 | Feb 14, 2022 | — |
| SC 13G | SCHEDULE 13G | 0001104659-22-018327 | Feb 10, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-034461 | Feb 10, 2022 | — |
| 8-K | 8-K | 0001193125-22-032678 | Feb 9, 2022 | — |
| 8-K | 8-K | 0001193125-22-016547 | Jan 25, 2022 | Jan 19, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-004488 | Jan 21, 2022 | Jan 19, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-004496 | Jan 21, 2022 | Jan 19, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-004492 | Jan 21, 2022 | Jan 19, 2022 |
| 10-Q | 10-Q | 0001564590-21-055073 | Nov 8, 2021 | Sep 30, 2021 |
| 8-K | 8-K | 0001193125-21-322361 | Nov 8, 2021 | — |
| 424B5 | 424B5 | 0001193125-21-307940 | Oct 26, 2021 | — |
| 8-K | 8-K | 0001193125-21-300530 | Oct 18, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-060109 | Oct 8, 2021 | Oct 7, 2021 |
| 8-K | 8-K | 0001193125-21-283009 | Sep 27, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-057517 | Sep 23, 2021 | Sep 21, 2021 |
| 8-K | 8-K | 0001193125-21-276774 | Sep 20, 2021 | Sep 17, 2021 |
| 8-K | 8-K | 0001193125-21-267309 | Sep 8, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-052287 | Aug 18, 2021 | Aug 16, 2021 |
| 8-K | 8-K | 0001193125-21-241228 | Aug 10, 2021 | — |
| 10-Q | 10-Q | 0001564590-21-042895 | Aug 10, 2021 | Jun 30, 2021 |
| 8-K | 8-K | 0001193125-21-236995 | Aug 5, 2021 | Aug 4, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-046678 | Jul 14, 2021 | Jul 13, 2021 |
| 8-K | 8-K | 0001193125-21-210772 | Jul 8, 2021 | Jul 2, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-043851 | Jun 29, 2021 | Jun 28, 2021 |
| 3 | FORM 3 SUBMISSION | 0001209191-21-039875 | Jun 11, 2021 | Jun 4, 2021 |
| 8-K | 8-K | 0001193125-21-182893 | Jun 4, 2021 | Jun 3, 2021 |
| 8-K | 8-K | 0001193125-21-172335 | May 25, 2021 | May 20, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-035479 | May 24, 2021 | May 21, 2021 |
| 4 | FORM 4 SUBMISSION | 0001209191-21-035482 | May 24, 2021 | May 21, 2021 |